GAS5 and hepatocellular carcinoma: Research has shown that METTL3‐mediated m6A modification promotes the binding of the m6A “reader” protein IGF2BP2 to GAS5, enhances the stability of GAS5, and thereby promotes the expression of GAS5 in HCC cells [18].